AtG Therapeutics is a breakthrough player in the oncology field and a recently created spinoff from Bellvitge Biomedical Research Institute (IDIBELL) and Catalan Institute of Oncology (ICO). AtG is developing a new treatment to prevent anti-angiogenics resistance, currently in the preclinical phase, and a prototype of a patient selector. This project was supported by international…
Inveniam Group is proud to announce the start of the BIOBOOST consortium. Inveniam will serve as project coordinator along with our partners Simbiosy, Aeris Environmental Technologies, and Roca Junyent. BIOBOOST is a project that is financed by the European Commission under the Circular Cities and Regions Initiative (CCRI) and has the main objective of catalyzing investments for…
On June 27, Inveniam Group’s managing partner Elena Canetti will participate in a round table discussion on Worldwide Best Practices in for Technology Transfer in HealthTech. This event is sponsored by Xartec Salut, a HealthTech research company based in Barcelona that supports the development of a better ecosystem and fosters entrepreneurship with innovative and exciting methodology. Elena Canetti…
Inveniam Group is made up of a diverse and multidisciplinary team that works together to bring breakthrough technologies to the market. Every month we will highlight one of our team members to get to know them and show who we are. For our eighth instalment we present, Max Kaczor. What interested you about working with…
On May 4th and 5th, 2022 the elephants team participated in the Kick-off Meeting of the TAONas-LUAD EIC Transition Grant at Centre for Genomic Regulation (CRG). Elena Canetti, Jesús Purroy, Cristina Vilarmau Marsinyach, and Isabel Espejo Díaz from Inveniam Group attended the event. We are honored to be an official member of this EIC consortium with CRG, SINTEF, and INSERM. The…
Inveniam Group is made up of a diverse and multidisciplinary team that works together to bring breakthrough technologies to the market. Every month we will highlight one of our team members to get to know them and show who we are. For our seventh instalment we present, Francesco Berni. What interested you about working with…
Inveniam Group is made up of a diverse and multidisciplinary team that works together to bring breakthrough technologies to the market. Every month we will highlight one of our team members to get to know them and show who we are. For our sixth instalment we present, Laia Mencia. What interested you about working with…
On March 3, 2022 Inveniam Group had the opportunity to participate in #BIOINVESTORSDAY, an event created to support projects in their funding pursuits. This event was organized by Bioincubatech who joined international investors to discover the latest trends in biotechnology applied to health and agrifood fields. Investors participated in virtual one-on-one meetings and round table…
Every month we will be featuring an article written by one of our team members about their fields of interest and what motivates them to change the world. For the fifth instalment of #ElephantsSpeak we have a post from one of our analysts, Max Kaczor. The computer age has given us unprecedented access to past…
Jesús Purroy, Director from the Inveniam Group, presented this morning at the Breakfast & Learn session from Xarxa TECSAM, offering a deep insight into different business models within the mental health industry. Jesús, an expert in technology transfer, revealed the four keys to keep in mind when considering a new medical solution, ensuring that it…